Search PubMed⌕ Search

Biomedical subjects

A C Page

Publications and source records attributed to A C Page.

26 records · Page 2Linked to original sources
PubMed1987

Evidence that epichlorohydrin is not a toxic metabolite of 1,2-dibromo-3-chloropropane.

The major urinary metabolite of 14C-epichlorohydrin, after oral administration to rats, was identified previously (Gingell et al. 1985) to be N-acetyl-S-(3-chloro-2-hydroxypropyl)-L-cysteine (ACPC) at 36% of the administered dose. In a similar study reported here, 1,2-dibromo-3-chloropropane (DBCP) was metabolized to at least 20 radioactive urinary metabolites. ACPC was only a minor metabolite (4%) of DBCP. Epichlorohydrin was metabolized in vitro by rat liver microsomes to alpha-chlorohydrin, but DBCP was not metabolized to epichlorohydrin or alpha-chlorohydrin under similar conditions. Covalent binding of radioactivity to liver microsomal proteins occurred for both substrates, but was less for 14C-epichlorohydrin than for 14C-DBCP. Addition of 3,3,3-trichloropropylene oxide, an inhibitor of epoxide hydrolase, increased the extent of protein binding of epichlorohydrin, but decreased the amount of 14C-DBCP which was bound. The data indicate the epichlorohydrin is not a significant in vivo nor in vitro metabolite of DBCP in the rat, and is unlikely to be responsible for the toxicity of DBCP.

Animals↗
PubMed1986

Critical evaluation of the radial head-capitellum view in elbow trauma.

The radial head-capitellum view, a radiographic projection of the elbow to show the lateral components, has been advocated for routine use in the investigation of acute elbow trauma. Retrospective and prospective studies in an Accident and Emergency Department were conducted to determine objective benefits in primary diagnostic rate and treatment. None were found, and thus it is suggested the view be for specialized use only when indicated.

Elbow Joint↗
PubMedDate not supplied

The "medicinal effect": a possible mechanism in the development of severe alcohol dependence.

An examination of the change in attractiveness of a flavor subsequent to pairing with recuperation from malaise was undertaken. Forty-five subjects consumed a flavor after the rotation-induced motion sickness at two different intervals. Twenty-four consumed, on three separate conditioning trials, the paired flavor immediately as malaise began to decline (short-delay group), the remainder, when malaise had completely diminished (long-delay group). All subjects also consumed an unpaired flavor the morning after each session. Analysis of variance revealed that the paired flavor was rated as more highly attractive than the unpaired flavor, and this effect was only present in the short delay group. These results were taken as supporting the existence of conditioned flavor preferences in humans and interpreted as a possible learning mechanism in the development of severe alcohol dependence.

Adult↗
PubMedDate not supplied

Disposition and metabolism of [2-14C]epichlorohydrin after oral administration to rats.

A comprehensive disposition and metabolism study of epichlorohydrin (ECH) has not been previously reported. In this study, male Fischer 344 rats were dosed (6 mg/kg) orally with [2-14C]ECH (98% radiochemically pure) as an aqueous solution and killed after 3 days. Approximately 38% of the radioactive dose was exhaled as CO2, 50% was excreted as metabolites in the urine, and 3% was present in the feces. Radioactivity in tissues accounted for the remainder of the administered dose. When expressed per gram of tissue, radioactivity was highest in liver, kidney, and forestomach. The half-life of initial elimination of radioactivity in both the urine and exhaled air was about 2 hr, indicating that ECH was rapidly absorbed and metabolized. The major metabolites in the urine were identified as N-acetyl-S-(3-chloro-2-hydroxypropyl)-L-cysteine and alpha-chlorohydrin, about 36 and 4% of the administered dose, respectively. Finding these metabolites, which have not been previously reported, is consistent with the initial metabolic reactions being conjugation of the epoxide with glutathione and hydration of the epoxide.

Administration, Oral↗